Acetaminophen / Ibuprofen
Acetaminophen / ibuprofen is a combination pain reliever used to temporarily reduce mild to moderate pain from headaches, backache, muscle aches, menstrual cramps, toothache, and minor arthritis pain.
🧬 Where this information comes from Click to expand
The clinical label records used on this page are FDA-filed Structured Product Labeling (SPL) retrieved through openFDA. We identified 74 clinical label sets within the page’s selected clinical scope after exact ingredient or ingredient-combination matching and applicable route/form matching. Forms, routes, brands, labelers, strengths, and NDC product-record counts are built separately from matching FDA National Drug Code Directory records. The linked DailyMed document is a representative official source for verification, not the page’s only clinical source. View the linked label on DailyMed →
⚠️ FDA Boxed Warning — the FDA’s strongest safety alert ▾
Combogesic IV carries three serious boxed warnings from the FDA.
Liver risk: Combogesic IV contains acetaminophen, which has been linked to acute liver failure — sometimes requiring a liver transplant or causing death. This is most common when acetaminophen doses exceed 4,000 mg per day or when multiple acetaminophen-containing products are used together. Extra care must be taken to avoid dosing errors with the IV form, since mistakes can cause accidental overdose and death.
Heart risk: Combogesic IV contains ibuprofen, an NSAID. NSAIDs increase the risk of serious heart attack and stroke, which can be fatal. This risk can appear early in treatment and grows with longer use. Combogesic IV must not be used in patients having coronary artery bypass graft (CABG) heart surgery.
Stomach/GI risk: NSAIDs can cause life-threatening bleeding, ulcers, or tears in the stomach or intestines at any time — often without any warning signs. Older adults are at especially high risk.
📖 Acetaminophen / Ibuprofen: Patient Information Guide
A plain-language walkthrough of Acetaminophen / Ibuprofen — what it treats, how it works, how it’s taken, side effects, warnings and interactions. Tap any section to expand it.
🎯What it's used for▾
Acetaminophen/ibuprofen combination products are used to relieve pain across a range of everyday conditions. Specific indications vary by product and route:
- Temporary relief of minor aches and pains from headache
- Temporary relief of toothache
- Temporary relief of backache
- Temporary relief of menstrual cramps
- Temporary relief of muscular aches
- Temporary relief of minor pain of arthritis
- Combogesic IV (intravenous injection, for adults only in a clinical setting): relief of mild to moderate pain, or as an add-on to opioid analgesics for moderate to severe pain — for short-term use of five days or less
⚙️How it works▾
This combination contains two distinct pain-relieving ingredients that work through different pathways. Acetaminophen is thought to act mainly in the central nervous system to reduce the perception of pain, though its precise mechanism isn't fully understood. Ibuprofen is an NSAID (nonsteroidal anti-inflammatory drug) that blocks COX-1 and COX-2 enzymes, reducing the body's production of prostaglandins — chemicals that amplify pain signals and cause inflammation at the site of injury. Together, they target pain from more than one angle.
💊How it's taken▾
The right way to take this medication depends on the specific product. Oral tablets are generally taken every 8 hours while symptoms last, and should not exceed 6 tablets in 24 hours for most OTC products — unless a doctor advises otherwise. You can take tablets with food or milk if they cause stomach upset. Combogesic IV is given by a healthcare provider as a 15-minute intravenous infusion every 6 hours as needed, for no more than five days.
- Never take more than directed — do not exceed the maximum daily amount
- Do not combine with other acetaminophen-containing products
- Children under 12 should use oral tablets only under a doctor's guidance
- Always follow your specific product label or your prescriber's instructions
🤒Side effects — in detail▾
Common side effects reported in clinical studies of Combogesic IV include:
- Nausea
- Vomiting
- Constipation
- Dizziness
- Headache
- Drowsiness
- Infusion site pain (Combogesic IV)
- Infusion site leakage/swelling — extravasation (Combogesic IV)
Serious reactions requiring immediate medical attention include signs of stomach bleeding (vomiting blood, black or bloody stools), signs of heart attack or stroke (chest pain, sudden weakness, slurred speech), severe allergic reactions (swelling of the face or throat, wheezing, severe rash or blisters), and any signs of liver problems such as unusual fatigue or yellowing of the skin.
⚠️Warnings & precautions▾
- Liver damage risk (acetaminophen): Taking too much acetaminophen — especially from multiple products at once — can cause acute liver failure that may require a transplant or be fatal. Do not exceed the maximum daily dose from all sources. Drinking 3 or more alcoholic drinks daily while using this product raises liver risk further.
- Heart attack and stroke risk (ibuprofen/NSAID): NSAIDs increase the risk of serious, potentially fatal cardiovascular events including heart attack and stroke. This risk may begin within the first weeks of treatment. People with existing heart disease or risk factors are at highest absolute risk. This product must not be used around the time of coronary artery bypass graft (CABG) surgery.
- Stomach/GI bleeding (ibuprofen/NSAID): NSAIDs can cause serious bleeding, ulcers, or perforations in the stomach or intestines — often without warning. Risk is higher in people over 60, those with a history of ulcers, those taking blood thinners or steroids, and those who drink alcohol regularly.
- Kidney effects: Long-term NSAID use can damage the kidneys. People who are elderly, dehydrated, or have existing kidney, liver, or heart problems are at greatest risk. This product is not recommended for those with significant kidney or liver impairment.
- Pregnancy: Avoid ibuprofen at 20 weeks of pregnancy or later unless clearly directed by a doctor, due to risks to the developing baby's kidneys and heart.
🔀What it interacts with▾
This combination can interact with several common medications and substances — always tell your pharmacist and prescriber everything you take:
- Other acetaminophen products — doubles your acetaminophen exposure and raises the risk of liver damage
- Alcohol — increases both liver damage risk (from acetaminophen) and stomach bleeding risk (from ibuprofen)
- Blood thinners (e.g., warfarin) — ibuprofen adds to bleeding risk
- Aspirin — ibuprofen may reduce aspirin's heart-protective effect; combining also raises stomach bleeding risk
- SSRIs/SNRIs (antidepressants) — increases bleeding risk in combination with ibuprofen
- ACE inhibitors, ARBs, beta-blockers, diuretics — ibuprofen can reduce their blood pressure and fluid-control effectiveness, and can worsen kidney function when combined
- Lithium — ibuprofen can raise lithium blood levels, increasing toxicity risk
- Digoxin — ibuprofen may increase digoxin blood levels
- Methotrexate or cyclosporine — ibuprofen can increase the risk of toxicity from these medicines
This is not a complete list of interactions. Always talk with your doctor or pharmacist before starting, stopping, or changing any medication.
📋Before taking it▾
- Do not use if you are allergic to acetaminophen, ibuprofen, aspirin, or any other NSAID
- Do not use if you have ever had asthma, hives, or an allergic reaction after taking aspirin or NSAIDs
- Do not use around the time of coronary artery bypass graft (CABG) heart surgery
- Tell your doctor if you have liver disease, kidney disease, heart disease, high blood pressure, or have had a stroke
- Tell your doctor if you have a history of stomach ulcers, stomach bleeding, or GI problems
- Tell your doctor if you take a diuretic, aspirin for heart protection, or blood thinners
- Pregnant individuals should consult a health professional before use; avoid ibuprofen at 20 weeks of pregnancy or later unless clearly directed by a doctor
- If breastfeeding, ask a health professional before use
- Older adults are at higher risk for stomach bleeding and kidney effects — use the lowest amount for the shortest time
- Do not give to children under 12 without a doctor's guidance
- Combogesic IV is not recommended for patients with severe liver impairment, significant kidney impairment, or severe heart failure (unless benefits outweigh risks)
🚑If you take too much▾
Taking too much of this combination can cause signs of acetaminophen toxicity, ibuprofen toxicity, or both. Early signs of acetaminophen overdose include nausea, vomiting, loss of appetite, and sweating — but serious liver damage may not appear until 48 to 72 hours later, even if you feel okay at first. If you suspect an overdose, call Poison Control at 1-800-222-1222 or get emergency medical help right away — prompt treatment is critical for both adults and children even without obvious symptoms.
📡Pharmacodynamics — effects in the body▾
Ibuprofen, as an NSAID, inhibits platelet aggregation (the clumping of blood cells involved in clotting) and can prolong bleeding time in some people. Unlike aspirin, this effect on platelets is smaller in magnitude, shorter-lasting, and reversible when the drug is stopped.
🔬Pharmacokinetics — how your body processes it▾
When taken as oral tablets, acetaminophen reaches peak blood levels in about 45 minutes and ibuprofen in about 75 minutes under fasting conditions. Taking tablets with food delays acetaminophen's peak by roughly 30 minutes but doesn't meaningfully change how much is absorbed overall. Acetaminophen is broken down mainly in the liver and has a half-life (the time for blood levels to drop by half) of about 2 to 3 hours in adults; ibuprofen has a half-life of roughly 2 hours and is almost completely cleared by the kidneys within 24 hours of the last dose.
📦How to store it▾
Store at 20°C to 25°C (68°F to 77°F) with excursions permitted within USP controlled room temperature of 15°C to 30°C (59°F to 86°F). Protect from moisture and light.
📄 Written from Acetaminophen / Ibuprofen’s FDA-approved label information, summarized in plain language with AI, and reviewed by our pharmacy team before publication. Every point is grounded in that labeling — nothing is invented. How we use AI →
🩺 Pharmacist Counseling Corner
Quick, plain-English answers to the questions patients ask most about Acetaminophen / Ibuprofen — the kind of thing our pharmacy team would talk through with you at the counter.
Can I take this combination instead of just acetaminophen or just ibuprofen? ▾
Is it safe to take this with a drink or two? ▾
Can I check other medicines for acetaminophen overlap? ▾
I'm pregnant — is this safe to take? ▾
How long can I take this before it becomes a problem? ▾
What stomach symptoms should I actually worry about? ▾
Is Acetaminophen / Ibuprofen available over the counter? ▾
When was Acetaminophen / Ibuprofen first available? ▾
Who makes Acetaminophen / Ibuprofen? ▾
💬 Answers drafted from Acetaminophen / Ibuprofen’s FDA-approved label information, summarized in plain language with AI, and reviewed by our pharmacy team before publication. Grounded in that labeling — nothing is made up. How we use AI →
🧰 Keep exploring
💊 How Acetaminophen / Ibuprofen comes
Acetaminophen / Ibuprofen is available in 2 forms. Different forms and brands can have different approved uses, doses, schedules, and directions. Follow the instructions for your exact product, and do not switch forms without guidance from your prescriber or pharmacist.
Tablet
How this form is used
- Temporarily relieves minor aches and pains from headache, toothache, backache, menstrual cramps, muscular aches, and minor arthritis pain
- Acetaminophen and Ibuprofen Back Pain tablets are labeled for temporary relief of backache, muscular aches, minor arthritis pain, headache, toothache, and menstrual cramps
- Advil Dual Action With Acetaminophen tablets are labeled for temporary relief of backache, muscular aches, minor arthritis pain, headache, toothache, and menstrual cramps
- Adults and children 12 and over: take 2 tablets every 8 hours while symptoms persist; do not take more than 6 tablets in 24 hours unless directed by a doctor
- Children under 12 years: ask a doctor before use
- Take with food or milk if stomach upset occurs
- Do not use with any other product containing acetaminophen or another NSAID
Injection
How this form is used
- Combogesic IV is indicated in adults for relief of mild to moderate pain when IV administration is clinically necessary
- Combogesic IV is indicated in adults as an add-on to opioid pain medicines for moderate to severe pain when IV administration is clinically necessary
- Combogesic IV is approved for short-term use only — five days or less
- Combogesic IV is administered by a healthcare provider as a 15-minute intravenous infusion, every 6 hours as needed
- Combogesic IV dosing is based on the patient's actual body weight — those weighing less than 50 kg receive a weight-based dose
- Combogesic IV must not be given with other acetaminophen-containing products
- Use the lowest effective dose for the shortest duration consistent with treatment goals
📊 Acetaminophen / Ibuprofen across the U.S. market
How Acetaminophen / Ibuprofen appears in the FDA’s National Drug Code Directory — including its dosage forms, strengths, brand names, manufacturers, and FDA-listed product records. These are directory records, not sales or prescription volume.
FDA-listed product records by dose form (tablet variants merged) — FDA National Drug Code Directory. Record counts are not sales or prescription volume.
Share of FDA-listed product records by manufacturer — FDA National Drug Code Directory. Record counts are not sales or prescription volume.
📈 How widely Acetaminophen / Ibuprofen is used
A general measure of how commonly Acetaminophen / Ibuprofen is prescribed, based on Medicaid — one of the largest public drug programs. The figure below is prescriptions filled in Q1–Q4 2025, summed across every form and brand of the drug.
Think of this as a proxy for how widely Acetaminophen / Ibuprofen is used, drawn from freely available public data. Medicaid is just one program — these numbers don’t include Medicare, other government coverage, or commercial and cash-pay prescriptions, so real-world use is higher than what’s shown here.
How commonly is Acetaminophen / Ibuprofen prescribed? Of the 1,596 medications we measure, Acetaminophen / Ibuprofen ranks #1,575 by Medicaid prescriptions — more than 1% of them.
Utilization by Acetaminophen / Ibuprofen product
Pick a product to see its own Medicaid numbers. Each chip is one clinical product — a specific strength & dosage form as defined by RxNorm — with brand-name and generic versions combined.
acetaminophen 250 MG / ibuprofen 125 MG Oral Tablet
Summed across the 1 of 216 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 2387532
Shares are of the Medicaid prescriptions shown here. Product grouping follows RxNorm (the National Library of Medicine’s drug terminology), so “one product” means one strength & dosage form regardless of manufacturer. Dollar figures are gross Medicaid reimbursement before mandatory rebates — rebates (often large, especially for brand-name drugs) are confidential, so actual net cost to Medicaid is lower than shown.
Source: Medicaid State Drug Utilization Data (CMS), aggregated by generic ingredient — summed across every NDC (all brands, strengths, salt forms and dosage forms) of Acetaminophen / Ibuprofen, and across all states and both fee-for-service and managed-care claims. A general popularity signal; it excludes Medicare, commercial insurance and cash prescriptions, so it is not total U.S. use. Based on the 1 of 216 listed Acetaminophen / Ibuprofen NDCs with Medicaid activity.
🔍 Compare Acetaminophen / Ibuprofen products
A representative set of FDA-listed product records for Acetaminophen / Ibuprofen — across manufacturers, strengths, and dosage forms, grouped by form with each product’s manufacturer and how the FDA approved it. The same medicine may be made and packaged by different companies, so a single drug can have many directory entries. (It’s also why a refill can look different — a new shape, color, or box — even though it contains the same medication.)
| Strength | Route | Manufacturer / Labeler | Category ⓘ | Details |
|---|---|---|---|---|
| 💊Injection | ||||
| ACETAMINOPHEN 1000 mg/100 mL; IBUPROFEN 300 mg/100 mL | Intravenous | Hikma Pharmaceuticals USA Inc. | NDA | View NDC → |
| 💊Tablet | ||||
| ACETAMINOPHEN 325 mg/1; IBUPROFEN 97.5 mg | Oral | AFT Pharmaceuticals US, Inc. × 3 listings | NDA | View NDC → |
| ACETAMINOPHEN 250 mg/1; IBUPROFEN 125 mg | Oral | Amazon.com Services LLC × 2 listings | ANDA | View NDC → |
| IBUPROFEN 125 mg/1; ACETAMINOPHEN 250 mg | Oral | Amerisource Bergen × 2 listings | ANDA | View NDC → |
| 250; 125 mg/1; mg | Oral | Amerisource Bergen | ANDA | View NDC → |
| ACETAMINOPHEN 250 mg/1; IBUPROFEN 125 mg | — | Aurobindo Pharma Limited × 2 listings | DRUG FOR FURTHER PROCESSING | View NDC → |
| ACETAMINOPHEN 250 mg/1; IBUPROFEN 125 mg | Oral | Aurohealth LLC × 2 listings | ANDA | View NDC → |
| ACETAMINOPHEN 250 mg/1; IBUPROFEN 125 mg | Oral | Better Living Brands, Llc | ANDA | View NDC → |
| 250; 125 mg/1; mg | Oral | Better Living Brands, Llc | ANDA | View NDC → |
| IBUPROFEN 125 mg/1; ACETAMINOPHEN 250 mg | Oral | Bionpharma Inc. × 4 listings | ANDA | View NDC → |
| IBUPROFEN 125 mg/1; ACETAMINOPHEN 250 mg | — | Bionpharma Inc. | DRUG FOR FURTHER PROCESSING | View NDC → |
| 250; 125 mg/1; mg | Oral | Bionpharma Inc. | ANDA | View NDC → |
| ACETAMINOPHEN 325 mg/1; IBUPROFEN 97.5 mg | Oral | Bryant Ranch Prepack | NDA | View NDC → |
| ACETAMINOPHEN 250 mg/1; IBUPROFEN 125 mg | Oral | Cardinal Health 110, LLC. dba Leader × 2 listings | ANDA | View NDC → |
| IBUPROFEN 125 mg/1; ACETAMINOPHEN 250 mg | Oral | Chain Drug Marketing Association Inc. × 2 listings | ANDA | View NDC → |
| ACETAMINOPHEN 1 mg/1; IBUPROFEN 125 mg | Oral | Cvs | ANDA | View NDC → |
| IBUPROFEN 125 mg/1; ACETAMINOPHEN 250 mg | Oral | Cvs | ANDA | View NDC → |
| ACETAMINOPHEN 250 mg/1; IBUPROFEN 125 mg | Oral | Cvs | ANDA | View NDC → |
| 250; 125 mg/1; mg | Oral | Cvs × 2 listings | ANDA | View NDC → |
| IBUPROFEN 125 mg/1; ACETAMINOPHEN 250 mg | Oral | CVS Pharmacy | ANDA | View NDC → |
| ACETAMINOPHEN 250 mg/1; IBUPROFEN 125 mg | Oral | CVS Pharmacy × 2 listings | ANDA | View NDC → |
| IBUPROFEN 125 mg/1; ACETAMINOPHEN 250 mg | Oral | Discount Drug Mart, Inc. | ANDA | View NDC → |
| 250; 125 mg/1; mg | Oral | Discount Drug Mart, Inc. | ANDA | View NDC → |
| ACETAMINOPHEN 250 mg/1; IBUPROFEN 125 mg | Oral | Dolgencorp Inc × 2 listings | ANDA | View NDC → |
| IBUPROFEN 125 mg/1; ACETAMINOPHEN 250 mg | Oral | Dr. Reddy's Labortories Inc | ANDA | View NDC → |
| ACETAMINOPHEN 250 mg/1; IBUPROFEN 125 mg | Oral | Family Dollar | ANDA | View NDC → |
| 250; 125 mg/1; mg | Oral | Family Dollar | ANDA | View NDC → |
| 250; 125 mg/1; mg | Oral | GlaxoSmithKline Consumer Healthcare Holdings (US) LLC × 3 listings | NDA | View NDC → |
| IBUPROFEN 125 mg/1; ACETAMINOPHEN 250 mg | Oral | Glenmark Therapeutics Inc., Usa | ANDA | View NDC → |
| ACETAMINOPHEN 250 mg/1; IBUPROFEN 125 mg | — | Granules India Limited | DRUG FOR FURTHER PROCESSING | View NDC → |
| ACETAMINOPHEN 250 mg/1; IBUPROFEN 125 mg | Oral | Granules Pharmaceuticals Inc. × 2 listings | ANDA | View NDC → |
| 250; 125 mg/1; mg | Oral | Granules Pharmaceuticals Inc. | ANDA | View NDC → |
| ACETAMINOPHEN 250 mg/1; IBUPROFEN 125 mg | Oral | Granules Usa, Inc. | ANDA | View NDC → |
| IBUPROFEN 125 mg/1; ACETAMINOPHEN 250 mg | Oral | Haleon US Holdings LLC × 2 listings | NDA | View NDC → |
| IBUPROFEN 125 mg/1; ACETAMINOPHEN 250 mg | — | Haleon US Holdings LLC | DRUG FOR FURTHER PROCESSING | View NDC → |
| ACETAMINOPHEN 325 mg/1; IBUPROFEN 97.5 mg | Oral | Hikma Pharmaceuticals USA Inc | NDA | View NDC → |
| ACETAMINOPHEN 250 mg/1; IBUPROFEN 125 mg | Oral | HyVee Inc | ANDA | View NDC → |
| 250; 125 mg/1; mg | Oral | Johnson & Johnson Consumer Inc. | ANDA | View NDC → |
| ACETAMINOPHEN 250 mg/1; IBUPROFEN 125 mg | Oral | Kai Squared | ANDA | View NDC → |
| IBUPROFEN 125 mg/1; ACETAMINOPHEN 250 mg | Oral | Kenvue Brands LLC | ANDA | View NDC → |
| ACETAMINOPHEN 250 mg/1; IBUPROFEN 125 mg | Oral | Kroger Company × 2 listings | ANDA | View NDC → |
| 250; 125 mg/1; mg | Oral | Kroger Company | ANDA | View NDC → |
| ACETAMINOPHEN 250 mg/1; IBUPROFEN 125 mg | Oral | L.N.K. International, Inc. | ANDA | View NDC → |
| ACETAMINOPHEN 250 mg/1; IBUPROFEN 125 mg | Oral | L. Perrigo Company | ANDA | View NDC → |
| ACETAMINOPHEN 250 mg/1; IBUPROFEN 125 mg | Oral | LEADER/ Cardinal Health 110, Inc. | ANDA | View NDC → |
| 250; 125 mg/1; mg | Oral | LEADER/ Cardinal Health 110, Inc. | ANDA | View NDC → |
| ACETAMINOPHEN 250 mg/1; IBUPROFEN 125 mg | Oral | L Perrigo Company × 2 listings | ANDA | View NDC → |
| ACETAMINOPHEN 250 mg/1; IBUPROFEN 125 mg | — | L Perrigo Company | DRUG FOR FURTHER PROCESSING | View NDC → |
| ACETAMINOPHEN 250 mg/1; IBUPROFEN 125 mg | Oral | Marksans Pharma Limited | ANDA | View NDC → |
| 250; 125 mg/1; mg | Oral | Marksans Pharma Limited | ANDA | View NDC → |
| ACETAMINOPHEN 250 mg/1; IBUPROFEN 125 mg | Oral | Meijer, Inc. × 3 listings | ANDA | View NDC → |
| IBUPROFEN 125 mg/1; ACETAMINOPHEN 250 mg | Oral | Meijer Distribution Inc | ANDA | View NDC → |
| IBUPROFEN 125 mg/1; ACETAMINOPHEN 250 mg | Oral | Navajo Manufacturing Company Inc. | NDA | View NDC → |
| 250; 125 mg/1; mg | Oral | Navajo Manufacturing Company Inc. | NDA | View NDC → |
| ACETAMINOPHEN 325 mg/1; IBUPROFEN 97.5 mg | Oral | Preferred Pharmaceuticals Inc. × 2 listings | NDA | View NDC → |
| ACETAMINOPHEN 250 mg/1; IBUPROFEN 125 mg | Oral | Publix Super Markets Inc | ANDA | View NDC → |
| ACETAMINOPHEN 250 mg/1; IBUPROFEN 125 mg | — | Recipharm pharmaservices Private Limited | DRUG FOR FURTHER PROCESSING | View NDC → |
| IBUPROFEN 125 mg/1; ACETAMINOPHEN 250 mg | Oral | Retail Business Services,llc | ANDA | View NDC → |
| ACETAMINOPHEN 250 mg/1; IBUPROFEN 125 mg | Oral | Retail Business Services, LLC | ANDA | View NDC → |
| 250; 125 mg/1; mg | Oral | Retail Business Services,llc | ANDA | View NDC → |
| IBUPROFEN 125 mg/1; ACETAMINOPHEN 250 mg | Oral | Rite Aid | ANDA | View NDC → |
| 250; 125 mg/1; mg | Oral | Rite Aid | ANDA | View NDC → |
| ACETAMINOPHEN 250 mg/1; IBUPROFEN 125 mg | Oral | Rite Aid Corporation × 2 listings | ANDA | View NDC → |
| 250; 125 mg/1; mg | Oral | Rite Aid Corporation | ANDA | View NDC → |
| ACETAMINOPHEN 250 mg/1; IBUPROFEN 125 mg | Oral | R J General Corporation | OTC MONOGRAPH DRUG | View NDC → |
| ACETAMINOPHEN 250 mg/1; IBUPROFEN 125 mg | Oral | Rugby Laboratories | ANDA | View NDC → |
| 250; 125 mg/1; mg | Oral | Rugby Laboratories | ANDA | View NDC → |
| IBUPROFEN 125 mg/1; ACETAMINOPHEN 250 mg | Oral | Select Consumer Group | NDA | View NDC → |
| ACETAMINOPHEN 250 mg/1; IBUPROFEN 125 mg | Oral | Sportpharm LLC | ANDA | View NDC → |
| ACETAMINOPHEN 250 mg/1; IBUPROFEN 125 mg | Oral | Strategic Sourcing Services LLC × 2 listings | ANDA | View NDC → |
| ACETAMINOPHEN 250 mg/1; IBUPROFEN 125 mg | Oral | Sun Pharmaceutical Industries, Inc. | ANDA | View NDC → |
| IBUPROFEN 125 mg/1; ACETAMINOPHEN 250 mg | Oral | Target Corporation | ANDA | View NDC → |
| 250; 125 mg/1; mg | Oral | Target Corporation | ANDA | View NDC → |
| ACETAMINOPHEN 250 mg/1; IBUPROFEN 125 mg | Oral | Time Cap Laboratories, Inc. | ANDA | View NDC → |
| ACETAMINOPHEN 250 mg/1; IBUPROFEN 125 mg | Oral | Topco Associates LLC × 3 listings | ANDA | View NDC → |
| ACETAMINOPHEN 250 mg/1; IBUPROFEN 125 mg | Oral | United Natural Foods, Inc. dba UNFI × 2 listings | ANDA | View NDC → |
| IBUPROFEN 125 mg/1; ACETAMINOPHEN 250 mg | Oral | Wal-Mart Stores Inc. × 2 listings | ANDA | View NDC → |
| IBUPROFEN 125 mg/1; ACETAMINOPHEN 250 mg | Oral | Walgreen Company | ANDA | View NDC → |
| ACETAMINOPHEN 250 mg/1; IBUPROFEN 125 mg | Oral | Walgreen Company × 3 listings | ANDA | View NDC → |
| 250; 125 mg/1; mg | Oral | Walgreen Company | ANDA | View NDC → |
| ACETAMINOPHEN 250 mg/1; IBUPROFEN 125 mg | Oral | Walgreens | ANDA | View NDC → |
| 250; 125 mg/1; mg | Oral | Walgreens | ANDA | View NDC → |
| ACETAMINOPHEN 250 mg/1; IBUPROFEN 125 mg | Oral | Walmart Inc. × 3 listings | ANDA | View NDC → |
Showing 116 of 116 products — FDA National Drug Code Directory. See every product, package size and price: browse all 116 Acetaminophen / Ibuprofen NDCs →
📈 What people report — real-world data (FDA FAERS)
After a medicine reaches the market, patients, doctors and drugmakers can send the FDA reports of problems they think may be linked to it. Here’s what’s been reported for Acetaminophen / Ibuprofen — a signal of what to watch for, not proof the drug caused it.
Source: openFDA, from the FDA Adverse Event Reporting System (FAERS). These are voluntary reports — they don’t prove the drug caused the effect, and counts reflect how often something was reported, not how often it actually happens. Reports also often name the very problem the medicine is taken for — a common reason to file one is that the drug didn’t help — so for a pain reliever you may see “pain” high on the list; that points to why the report was filed, not to the drug causing the symptom. This counts every report that lists Acetaminophen / Ibuprofen in any role, so the total runs higher than the FDA’s official dashboard, which counts only cases where the drug is the suspect. For the authoritative figures, see the FDA FAERS Public Dashboard. Always talk to your pharmacist or doctor.
🏛️ The road to your pharmacy
How Acetaminophen / Ibuprofen went from FDA review to the pharmacy shelf — the key milestones in its regulatory journey.
Source: Drugs@FDA.
🚨 Recall history
A recall is when a specific batch of a medicine is pulled from the market — usually a manufacturing issue, not a problem with the drug itself. Class I is most serious, Class III least.
Source: openFDA drug enforcement (recall) reports.
RxNorm Concept Web — From Ingredient to Every Form and Strength
This page starts with one exact multiple-ingredient concept (MIN). The branches below show its dose-form concepts (SCDF), then the available clinical drug and strength concepts (SCD). A product with a different ingredient combination belongs on a different page.
RxCUI 818102 3 dose forms · 4 strengths
-
Dose form (SCDF) Injection RxCUI 2673873In current FDA listingsClinical drug / strength (SCD) 100 ML acetaminophen 10 MG/ML / ibuprofen 3 MG/MLRxCUI 2673874 -
Dose form (SCDF) Oral Suspension RxCUI 372451No current FDA listingClinical drug / strength (SCD) acetaminophen 25 MG/ML / ibuprofen 20 MG/MLRxCUI 250085 -
Dose form (SCDF) Oral Tablet RxCUI 372452In current FDA listingsClinical drug / strength (SCD) acetaminophen 250 MG / ibuprofen 125 MGRxCUI 2387532acetaminophen 325 MG / ibuprofen 97.5 MGRxCUI 2675760
Look up RxCUI 818102 in the RxCUI Atlas →
RxNorm is the U.S. National Library of Medicine’s normalized drug vocabulary. Its concept hierarchy can include forms that are not currently marketed; the status on each branch compares that concept with current FDA listings. RxCUIs identify vocabulary concepts, not individual packages or manufacturers.
📦 Supply & shortage status
Whether Acetaminophen / Ibuprofen is in short supply in the U.S. right now, plus any shortage history the FDA has on record. A shortage usually reflects a manufacturing or demand issue — not a safety problem with the drug.
Source: openFDA, from the FDA Drug Shortages database.
🏷️ Sold under these brand names
🏭 Manufacturers & labelers
…and 16 more on the FDA NDC directory.
RxNorm drug class
Acetaminophen / Ibuprofen belongs to the Anilides class.
Classified by RxNorm RxClass — the U.S. National Library of Medicine's standardized drug-classification service (Established Pharmacologic Class from the FDA, the ATC drug family from the WHO, and mechanism of action). Reference only, not medical advice.
🔬 Where this comes from
Core label, product, RxNorm, safety, and utilization data on this page come from the sources identified below. AI-written, editorial, and licensed sections are labeled separately.
How we combine label and product data
HelloPharmacist combines public FDA and NLM records; we don’t author the underlying clinical facts. We identified 74 FDA-filed SPL label sets within the page’s selected clinical scope after exact ingredient or ingredient-combination matching and applicable route/form matching. The representative label is the starting point for the displayed reference monograph; the 12 largest stored in-scope SPL records, which may include that representative, are compared section by section, and the longest available version of each section is retained. Forms, routes, brands, labelers, product-listed strengths, and product-record counts are aggregated separately from ingredient-matched FDA NDC Directory records; package records listed above are associated with the linked SPL; and the normalized concept hierarchy comes from NLM RxNorm.
For canonical ingredient pages, bounded product-attributed indication and administration excerpts may be added to the AI evidence, and the generator is instructed to preserve available product, brand, route, and form qualifiers instead of treating one label as universal. Where a section is identified as AI-written, its plain-language text is generated from bounded label evidence. New draft drug pages remain in the admin review queue before first publication. Preferred Pharmaceuticals Inc. is the representative DailyMed label linked for verification and dates; it is not the sole source used for the page.
This is general education, not medical advice — always consult your doctor or pharmacist about your medications and any medical condition. For the exact wording of the linked representative label, view that label on DailyMed; some displayed composite sections may come from other in-scope SPL labels. Learn how we use AI and our data sources & update cadence.